Jeffrey Rosen, MD
Sports Medicine · Flushing, NYNPI 1245226414
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $22,870 of the $37,263 with a category attached, or 61.4%. 20 manufacturers reported payments, led by Novartis Pharma AG at 52.1% of the total. Reporting peaked in 2021 at $16,323 and has fallen 86.7% since, to $2,163 in 2025.
Across 175 payments — averaging $212.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis Pharma AG$19K
- Stryker$6K
- Arthrex$5K
- Novartis$2K
- Ferring Pharmaceuticals Inc.$1K
- Amgen$842
- plus $3K from 14 others
Across 1 payment — averaging $24,113 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pacira Therapeutics, Inc.$24K
What the payments were for
- Consulting fees$22,87061%
- Speaking & faculty fees$3351%
- Travel & lodging$3,88110%
- Food & beverage$8,97724%
- Education$1,2003%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis Pharma AG | 7 | $19,400 |
| Stryker | 40 | $5,660 |
| Arthrex | 36 | $5,218 |
| Novartis | 1 | $2,160 |
| Ferring Pharmaceuticals Inc. | 7 | $1,428 |
| Amgen | 28 | $842 |
| Suvon Surgical LLC | 6 | $706 |
| Pacira Therapeutics, Inc. | 11 | $595 |
| Pacira Pharmaceuticals Incorporated | 5 | $389 |
| Johnson & Johnson | 16 | $345 |
| Acumed LLC | 3 | $214 |
| Fidia Pharma USA Inc. | 6 | $114 |
| Orthofix Medical, Inc. | 1 | $45 |
| Smith+Nephew | 1 | $36 |
| Convatec Inc. | 2 | $33 |
| Acell, Inc. | 1 | $24 |
| Anika Therapeutics, Inc. | 1 | $16 |
| Axogen | 1 | $16 |
| Baudax Bio Inc. | 1 | $12 |
| Gotham Surgical Solutions & Devices, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COSENTYX$19,160
- MAKO$4,152
- AIN457A_COSENTYX_DERMATOLOGY$2,400
- EUFLEXXA$1,310
- Zilretta$352
- GAMMA$336
- ALLOWRAP$314
- EXPAREL$285
- VITOSS$174
- HOFFMANN$174
- PANGEA$174
- AUGMENT INJECTABLE$174
- SALVATION$170
- ACUMED$146
- InFrame Implant$146
- TRIATHLON$134
- ORTHOVISC$119
- MONOVISC$119
- SHOULDER IMPLANTS FIBERTAK KNOTLESS$107
How this compares
$37,263 in reported general payments places this provider in the 85th percentile of 403 sports medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 20 | $72 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Flushing
- Mathew HamulaFlushing$60K
- Steven LeeNyc$3.3M
- James PaciWoodbury$2.1M
- Gregory DifeliceNew York$1.8M
- Ilya VoloshinRochester$786K
- Theodore BlaineNew York$765K
- Robert MeislinNew York$720K
- Danyal NawabiNew York$592K
- Stephen NicholasNyc$586K
- Riley WilliamsNew York$512K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.